Skip to search formSkip to main contentSkip to account menu

galsulfase

Known as: ARSB, Arylsufatase B, galsulfase [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

6 relations
5 ML galsulfase 1 MG/ML Injection [Naglazyme]Alpha-glucosidaseSulfatasesanalogs & derivatives

Broader (2)

Arylsulfatase BRecombinant Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Enzyme Replacement Therapy may Affect Blood Immunosupressant Monitoring.
BACKGROUND Although LC-MS/MS is preferred as a reliable method, therapeutic enzyme drugs in the blood matrix may lead to false… 
Review
2018
Review
2018
Clinical effectiveness of enzyme replacement therapy with galsulfase in mucopolysaccharidosis type VI treatment: systematic review
IntroductionMucopolysaccharidosis VI is a rare disease characterized by the arylsulfatase B enzyme deficiency, which is… 
2017
2017
Novel Mutations, Including a Large Deletion in the ARSB Gene, Causing Mucopolysaccharidosis Type VI.
OBJECTIVE Mucopolysaccharidosis type VI (MPS VI; Maroteaux-Lamy syndrome), a rare autosomal recessive lysosomal storage disease… 
2016
2016
Arylsulfatase B Mediates the Sulfonation-Transport Interplay in Human Embryonic Kidney 293 Cells Overexpressing Sulfotransferase 1A3
Elucidating the intricate relationships between metabolic and transport pathways contributes to improved predictions of in vivo… 
2016
2016
Abstract A34: Decline in Arylsulfatase B activates Wnt signaling by effects on DKK-3 methylation
Immunostaining and activity of the enzyme Arylsulfatase B (ARSB; N-acetylgalactosamine 4-sulfatase) were reduced in prostatic… 
2016
2016
Is premedication a necessity before galsulfase replacement therapy?
2014
2014
Evaluation of galsulfase for the treatment of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Introduction: Mucopolysaccharidosis VI (MPS VI) is an autosomal recessive lysosomal storage disorder caused by a deficiency in… 
2013
2013
Abstract 5205: Galectin-3 and AP-1 mediate transcriptional effect of Arylsulfatase B (N-acetylgalactosamine-4-sulfatase) on versican in prostatic cells.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC N-acetylgalactosamine-4-sulfatase (Arylsulfatase B… 
2012
2012
Mapping the Mechanism of the Resorcinol Ring Formation Catalyzed by ArsB, a Type III Polyketide Synthase from Azotobacter vinelandii
Who's first? Aldol cyclization occurs before hydrolysis in the resorcinol ring formation catalyzed by the type III polyketide… 
2010
2010
Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): a single dose of galsulfase further reduces urine glycosaminoglycans after hematopoietic stem cell transplantation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)